The notices it replaced
- Reissues: RFA-DA-22-038 Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)
- 2 steps back: PAR-19-368 Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
- 3 steps back: PAR-18-062 Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
- 4 steps back: PAR-16-234 Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)
- 5 steps back: PAR-13-080 Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)
- 6 steps back: PAR-10-018 Accelerating the Pace of Drug Abuse Research Using Existing Epidemiology, Prevention, and Treatment Research Data (R01)
Replaced by RFA-DA-26-056.
Who won it before
95 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $37,945,115 in first-year total cost, median $346,334.
Most frequent study sections
- Special Emphasis Panel[ZRG1 PSE-W (55)]42
- Special Emphasis Panel[ZRG1 PSE-P (55)]20
- Special Emphasis Panel[ZDA1 LXF-C (04)]3
- Behavioral Genetics and Epidemiology Study Section[BGES]2
- Interventions to Prevent and Treat Addictions Study Section[IPTA]2
Most frequent institutions
- UNIVERSITY OF MICHIGAN AT ANN ARBOR7
- YALE UNIVERSITY7
- JOHNS HOPKINS UNIVERSITY6
- RAND CORPORATION5
- NORTHWESTERN UNIVERSITY AT CHICAGO3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Understanding cannabidiol policy and its impacts on broader substance use1R21DA060486-01A1 | POWELL, DAVID | RAND CORPORATION, CA | $268,470 | ZDA1 |
| 2024 | The Cascade of Care for Patients with Opioid Use Disorder Identified Through a Large Public Health System1R21DA062182-01 | KALMIN, MARIAH | RAND CORPORATION, CA | $459,045 | ZDA1 |
| 2024 | "Cue Labeling as a Tool to Regulate Craving During Abstinence from Smoking”.1R21DA059798-01A1 | TABIBNIA, GOLNAZ | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $254,601 | ZDA1 |
| 2024 | Improving Causal Inference for National Adolescent Substance Use Datasets1R21DA059778-01A1 | MARCEAU, KRISTINE | PURDUE UNIVERSITY, IN | $235,500 | ZDA1 |
| 2024 | HIV Complex Causal Modeling: Gut Microbiome, Drug Use, and Immune Responses1R21DA061372-01 | MA, SHUANGGEYANG, BAO-ZHU | YALE UNIVERSITY, CT | $196,350 | ZDA1 |
| 2023 | Longitudinal Changes in Prescription Drug Misuse and Polysubstance Use in Adolescents and Young Adults2R01DA043691-04A1 · under PAR-19-368 | SCHEPIS, TY STEPHEN | TEXAS STATE UNIVERSITY, TX | $327,825 | SSPB |
| 2023 | Development of practical screening tools to support targeted prevention of early, high-risk drinking substance use1R21DA058314-01A1 | PELHAM III, WILLIAM ELLERBE | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $237,000 | ZDA1 |
| 2022 | Predict to Prevent: Dynamic Spatiotemporal Analyses of Opioid Overdose to Guide Pre-Emptive Public Health Responses1R01DA054267-01A1 · under PAR-19-368 | BAUER, CICISTOPKA, THOMAS J | TUFTS UNIVERSITY BOSTON, MA | $760,041 | CIHB |
| 2022 | Role of disability and pain in opioid overdose: mechanism and risk mitigation1R01DA053243-01A1 · under PAR-19-368 | RUDOLPH, KARA ELIZABETH | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $738,149 | BGES |
| 2022 | Leveraging data synthesis to identify optimal and robust strategies for HIV elimination among substance-using MSM1R01DA055502-01 · under PAR-19-368 | JANULIS, PATRICK FRANCIS | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $731,907 | ZRG1 |
| 2022 | Impact of Medicare Part D opioid safety policies on disabled beneficiaries before and during the COVID-19 pandemic1R01DA055131-01 · under PAR-19-368 | WEN, HEFEI | HARVARD PILGRIM HEALTH CARE, INC., MA | $701,067 | ODHS |
| 2022 | Insurance-related barriers to medications for opioid use disorder in private and Medicaid plans1R01DA056438-01 · under PAR-19-368 | CHUA, KAO-PINGNGUYEN, THUY DIEU | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $676,084 | ODHS |
| 2022 | Short-term Outcome of Stimulant Use Disorder Treatment Trials1R01DA054700-01A1 · under PAR-19-368 | MOJTABAI, RAMIN | JOHNS HOPKINS UNIVERSITY, MD | $409,375 | IPTA |
| 2022 | The Role of Behavior Therapy Combined with Buprenorphine for the Treatment of Opioid Use Disorder1R01DA054113-01A1 · under PAR-19-368 | MCHUGH, REBECCA KATHRYN | MCLEAN HOSPITAL, MA | $350,550 | IPTA |
| 2022 | Treatment Effect Heterogeneity in Psychosocial Treatments for Substance Use Disorders1R01DA053202-01A1 · under PAR-19-368 | SUSUKIDA, RYOKO | JOHNS HOPKINS UNIVERSITY, MD | $286,563 | BGES |
| 2022 | Neurocognitive Fingerprints of Substance Use and Misuse in Adolescents1R21DA057592-01 · under RFA-DA-22-038 | BASKIN-SOMMERS, ARIELLE RYANBRAZIL, INTI | YALE UNIVERSITY, CT | $252,999 | ZDA1 |
| 2022 | Clarifying the relations among youth technology use, substance use and mental health.1R21DA057535-01 · under RFA-DA-22-038 | BORODOVSKY, JACOB T | DARTMOUTH COLLEGE, NH | $246,000 | ZDA1 |
| 2022 | Recovery from Opioid Use Disorder: subgroups, transition states, and their association with recovery outcomes1R21DA057580-01 · under RFA-DA-22-038 | TEGGE, ALLISON N | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | $223,981 | ZDA1 |
| 2021 | MOUD Comparative Effectiveness Study1R01DA054268-01 · under PAR-19-368 | LAROCHELLE, MARC | BOSTON MEDICAL CENTER, MA | $602,367 | HSQE |
| 2021 | Elucidating Mechanisms of Pregnancy's Protective Effect on Drug Abuse Using Integrated Data Analysis1R01DA050700-01A1 · under PAR-19-368 | MASSEY, SUENA HUANG | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $601,811 | PDRP |
| 2021 | Intersectional Approaches to Population-Level Health Research: Role of HIV Risk and Mental Health in Alcohol Use Disparities among Diverse Sexual Minority Youth1R01AA029044-01A1 · under PAR-19-368 | PHILLIPS, GREGORY L. | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $588,270 | ZRG1 |
| 2021 | Spatio-temporal Methods for Surveillance of the Opioid Syndemic1R01DA052214-01A1 · under PAR-19-368 | HEPLER, STACIKLINE, DAVID M | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $387,459 | PPAH |
| 2020 | The Epidemiology of the Weiss Cohort Project1R01DA050495-01 · under PAR-18-062 | WEISS, STANLEY H | RBHS-NEW JERSEY MEDICAL SCHOOL, NJ | $779,861 | ZRG1 |
| 2020 | The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy1R01DA049822-01 · under PAR-18-062 | BATEMAN, BRIAN THOMASHUYBRECHTS, KRISTA F | BRIGHAM AND WOMEN'S HOSPITAL, MA | $737,855 | ZRG1 |
| 2020 | Estimating the population size of persons who inject drugs in New York1R01DA051302-01 · under PAR-18-062 | BRADLEY, HEATHERROSENBERG, ELI SAMUEL | GEORGIA STATE UNIVERSITY, GA | $666,970 | ZRG1 |
| 2020 | Opioid Policy Model1R01DA047994-01A1 · under PAR-18-062 | BOBASHEV, GEORGIY | RESEARCH TRIANGLE INSTITUTE, NC | $654,553 | ZRG1 |
| 2020 | Identifying blood-based DNA methylation biomarkers of cannabis use1R01DA048824-01A1 · under PAR-18-062 | FANG, FANG | RESEARCH TRIANGLE INSTITUTE, NC | $583,308 | ZRG1 |
| 2020 | Impact of in utero Marijuana Exposure on Neurodevelopment, Behavior and Mental Health: A Longitudinal Birth Cohort Study1R01DA048033-01A1 · under PAR-18-062 | AVALOS, LYNDSAY AMMONYOUNG-WOLFF, KELLY CORINNE | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $581,449 | ZRG1 |
| 2020 | Depressive Symptoms and Tobacco Use Trajectories and Transitions across Young Adulthood1R01CA249883-01A1 · under PAR-18-062 | LOUKAS, ALEXANDRA | UNIVERSITY OF TEXAS AT AUSTIN, TX | $399,623 | ZRG1 |
| 2020 | Increasing access to medication-assisted treatment: Interactions between federal and state workforce policies1R01DA047379-01A1 · under PAR-18-062 | SPETZ, JOANNE E. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $362,812 | ZRG1 |
| 2020 | Substance Use among Biracial Adolescents and Emerging Adults: The Double Jeopardy Hypothesis1R01DA051578-01 · under PAR-19-368 | GOINGS, TRENETTE CLARK | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $346,334 | SSPB |
| 2020 | Decoding the dynamic representation of reward predictions across mesocorticostriatal circuits during learning1R01DA050647-01 · under PAR-18-062 | NIV, YAEL | PRINCETON UNIVERSITY, NJ | $283,500 | ZRG1 |
| 2019 | Telemedicine for Treatment of Opioid Use Disorder1R01DA048533-01A1 · under PAR-18-062 | HUSKAMP, HAIDEN A.MEHROTRA, ATEEV | HARVARD MEDICAL SCHOOL, MA | $735,192 | ZRG1 |
| 2019 | Maternal Marijuana Use During Pregnancy, Marijuana Legalization, and Adverse Obstetrical and Neonatal Outcomes: A 12-year Cohort Study1R01DA047405-01A1 · under PAR-18-062 | AVALOS, LYNDSAY AMMONYOUNG-WOLFF, KELLY CORINNE | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $662,872 | ZRG1 |
| 2019 | Diagnostic and prognostic biomarkers for subtypes of addiction-related circuit dysfunction1R01DA047851-01A1 · under PAR-18-062 | GOLDSTEIN, RITA ZLISTON, CONOR M | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $621,348 | ZRG1 |
| 2019 | A decentralized macro and micro gene-by-environment interaction analysis of substance use behavior and its brain biomarkers1R01DA049238-01 · under PAR-18-062 | CALHOUN, VINCE DLIU, JINGYUSCHUMANN, GUNTER | GEORGIA STATE UNIVERSITY, GA | $551,746 | ZRG1 |
| 2019 | The Etiology of Risk: Alcohol and Drug Use Disorders and Suicidal Behavior1R01AA027522-01 · under PAR-18-062 | EDWARDS, ALEXIS CSUNDQUIST, KRISTINA | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $495,786 | ZRG1 |
| 2019 | Connectome-based prediction and neurodevelopmental trajectories of alcohol phenotypes across development1R01AA027553-01 · under PAR-18-062 | SCHEINOST, DUSTINYIP, SARAH | YALE UNIVERSITY, CT | $463,176 | ZRG1 |
| 2019 | Estimating the Effect of 24/7 Sobriety on Morbidity and Mortality in North Dakota1R01AA026457-01A1 · under PAR-18-062 | NICOSIA, NANCY | RAND CORPORATION, CA | $423,173 | ZRG1 |
| 2019 | Maternal use of prescribed opioid analgesics and risk of adverse offspring outcomes1R01DA048042-01 · under PAR-18-062 | D'ONOFRIO, BRIAN MOBERG, ANNA SARA | TRUSTEES OF INDIANA UNIVERSITY, IN | $423,021 | ZRG1 |
| 2019 | Alcohol Consumption and Cardiovascular Health Among Older Couples: The Roles of Genetics and Marital Quality1R01AA026687-01A1 · under PAR-18-062 | BIRDITT, KIRA S | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $411,863 | ZRG1 |
| 2019 | As adolescent substance use declines, internalizing symptoms increase: identifying high-risk substance using groups and the role of social media, parental supervision, and unsupervised time1R01DA048853-01 · under PAR-18-062 | KEYES, KATHERINE M. | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $403,284 | ZRG1 |
| 2019 | Disrupting Pathways from Early Adversity to Adult Substance Abuse: Identifying Education Resilience Factors in Diverse Groups1R01AA026956-01A1 · under PAR-18-062 | MULIA, NINA | PUBLIC HEALTH INSTITUTE, CA | $360,675 | ZRG1 |
| 2019 | Trajectories of Nonmedical Prescription Drug Misuse2R01DA031160-07 · under PAR-18-062 | MCCABE, SEAN ESTEBAN | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $358,800 | ZRG1 |
| 2018 | Researching Effective Strategies to Prevent Opioid Death (RESPOND)1R01DA046527-01 · under PAR-16-234 | LINAS, BENJAMIN P. | BOSTON MEDICAL CENTER, MA | $788,879 | ZRG1 |
| 2018 | Developing the evidence base for overdose policies: a multilevel analysis of NHBS1R01DA046197-01 · under PAR-16-234 | COOPER, HANNAH LF | EMORY UNIVERSITY, GA | $706,993 | ZRG1 |
| 2018 | ENIGMA- Addiction: Pooling of Existing Datasets to Identify Brain and Genetic Correlates of Addiction1R01DA047119-01 · under PAR-16-234 | CONROD, PATRICIAGARAVAN, HUGH P. | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $669,057 | ZRG1 |
| 2018 | Impact of Jail-Based Methadone on Overdose, Recidivism, HIV and Health Outcomes, and Costs in New York City, 2011-20171R01DA045042-01A1 · under PAR-16-234 | LEE, JOSHUA DLIM, SUNGWOOMACDONALD, ROSS | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $666,787 | ZRG1 |
| 2018 | Identifying Opioid Overdose Predictors using EHRs1R01DA045816-01 · under PAR-16-234 | BECKER, WILLIAM CLI, WENJUNYU, HONG | UNIVERSITY OF MASSACHUSETTS LOWELL, MA | $649,552 | ZRG1 |
| 2018 | Availability, accessibility, and structure of opioid use disorder treatment and maternal and child health outcomes1R01DA045675-01A1 · under PAR-16-234 | JARLENSKI, MARIAN PATRICIAKRANS, ELIZABETH E | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $601,948 | ZRG1 |
| 2018 | Computational and Neural Modeling of Cue Reactivity in Addiction1R01DA043695-01A1 · under PAR-16-234 | GU, XIAOSI | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $561,045 | ZRG1 |
| 2018 | Missing Data Matters: Substance Use Disorder Clinical Trials1R01DA046534-01 · under PAR-16-234 | SCHARFSTEIN, DANIEL OSCAR | JOHNS HOPKINS UNIVERSITY, MD | $543,369 | ZRG1 |
| 2018 | EpiCenter ? EPIdemiology of opioid prescribing in community health CENTERs1R01DA046468-01 · under PAR-16-234 | MUENCH, JOHN | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $524,707 | ZRG1 |
| 2018 | Estimating Mediation and Moderation Effects in HIV Incidence Prevention Trials1R01DA042666-01A1 · under PAR-16-234 | PITPITAN, EILEEN VIRTUSIO | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $514,112 | ZRG1 |
| 2018 | Using a Novel Comprehensive Linked Dataset to Determine Early Predictors of Opioid Overdose1R01DA044167-01A1 · under PAR-16-234 | WEINER, SCOTT GORDON | BRIGHAM AND WOMEN'S HOSPITAL, MA | $500,872 | ZRG1 |
| 2018 | MRI data fusion to investigate effects of drug abuse on HIV neurological complications1R01DA045565-01A1 · under PAR-16-234 | MEADE, CHRISTINA S | DUKE UNIVERSITY, NC | $412,771 | ZRG1 |
| 2018 | Integrative Prioritization of Alcohol and Drug-Addiction Related Genetic Loci1R01DA042742-01A1 · under PAR-16-234 | PALMER, ROHAN HUGH CRAIG | EMORY UNIVERSITY, GA | $298,047 | ZRG1 |
| 2018 | Prospective Examination of E-Cigarette Use, Tobacco Use Disorder and Health Consequences by U.S. Youth1R01DA044157-01A1 · under PAR-16-234 | BOYD, CAROL J | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $234,000 | ZRG1 |
| 2017 | Stop-and-Frisk, Arrest, and Incarceration and STI/HIV Risk in Minority MSM1R01DA044037-01A1 · under PAR-16-234 | KHAN, MARIA RABIA | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $759,749 | ZRG1 |
| 2017 | Meta-Analysis and Machine Learning: Towards Neuromarkers of Craving and Relapse1R01DA043690-01 · under PAR-16-234 | KOBER, HEDY | YALE UNIVERSITY, CT | $450,712 | ZRG1 |
| 2017 | Discrimination, Stress and Substance Use Disorder among Sexual Minority Adults: A Secondary Analysis of NESARC-III1R01DA043696-01A1 · under PAR-16-234 | BOYD, CAROL J | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $349,125 | ZRG1 |
| 2017 | Selection and Heterogeneity in the Effects of Alcohol Policies: Insights from a Natural Experiment1R01AA025622-01 · under PAR-16-234 | NICOSIA, NANCY | RAND CORPORATION, CA | $339,904 | ZRG1 |
| 2017 | Gender and Developmental Trajectories to Adolescent Substance Use and Sexual Risk Behavior1R01DA042747-01A1 · under PAR-16-234 | MIN, MEEYOUNG OH | CASE WESTERN RESERVE UNIVERSITY, OH | $296,001 | ZRG1 |
| 2017 | How drugs, crime and criminal justice involvement influence the lives and deaths of an urban African American cohort followed for 45 years1R01DA042748-01 · under PAR-13-080 | GREEN, KERRY M | UNIV OF MARYLAND, COLLEGE PARK, MD | $224,403 | ZRG1 |
| 2017 | Neuroimaging meta-analytics for addiction: Nodes, networks,and new heuristics1R01DA041353-01A1 · under PAR-13-080 | LAIRD, ANGELA RSUTHERLAND, MATTHEW T | FLORIDA INTERNATIONAL UNIVERSITY, FL | $215,214 | ZRG1 |
| 2017 | Diagnostic and prognostic methylation biomarkers for alcohol and related health risks1R01AA026057-01 · under PAR-16-234 | CLARK, SHAUNNA L | MICHIGAN STATE UNIVERSITY, MI | $209,250 | ZRG1 |
| 2017 | Prescription Drug Misuse Characteristics in Adolescents and Young Adults: Influence of School Enrollment1R01DA043691-01 · under PAR-16-234 | SCHEPIS, TY STEPHEN | TEXAS STATE UNIVERSITY, TX | $206,810 | ZRG1 |
| 2017 | Using existing data to understand and ameliorate risk in opioid agonist therapy1R01DA044170-01 · under PAR-16-234 | DEGENHARDT, LOUISA | UNIVERSITY OF NEW SOUTH WALES | $197,214 | ZRG1 |
| 2016 | A Model Averaging Approach to Causal Inference in Substance Abuse Prevention Research1R01DA040721-01A1 · under PAR-13-080 | HAN, BING | RAND CORPORATION, CA | $285,381 | ZRG1 |
| 2016 | Understanding the Beliefs, Concerns, and Needs of Pregnant Patients Who Use Marijuana and of the Obstetrics Providers Caring for Them1R56DA040617-01 · under PAR-13-080 | CHANG, JUDY C | MAGEE-WOMEN'S RES INST AND FOUNDATION, PA | $285,125 | ZRG1 |
| 2016 | The Impact of State Healthcare Reforms on Treatment of Substance Use Disorders1R01DA039863-01A1 · under PAR-13-080 | CRUM, ROSA M.MOJTABAI, RAMIN | JOHNS HOPKINS UNIVERSITY, MD | $255,581 | ZRG1 |
| 2016 | Functional networks related to cocaine dependence and its treatment and relapse1R01DA039136-01A1 · under PAR-13-080 | XU, JIANSONG | YALE UNIVERSITY, CT | $251,000 | ZRG1 |
| 2016 | Non-Medical Use of Prescription Opioids Among HIV-Infected Individuals: Trajectories and Impact on Health Outcomes1R01DA040471-01A1 · under PAR-13-080 | EDELMAN, E. JENNIFER | YALE UNIVERSITY, CT | $238,688 | ZRG1 |
| 2016 | The Intergeneration Effects of Criminal Justice Policies on Substance Use Crimes1R01DA040726-01A1 · under PAR-13-080 | ELDRED KOZECKE, LINDSEYGIFFORD, ELIZABETH JOANNESLOAN, FRANK A | DUKE UNIVERSITY, NC | $238,500 | ZRG1 |
| 2016 | Multilevel Moderators of Drugs, Violence, Poverty and HIV Among Black Youth and Young Adults Living in Baltimore2R01DA032550-04 · under PAR-13-080 | REBOUSSIN, BETH A. | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $236,797 | ZRG1 |
| 2016 | SMOKING, SUICIDE AND MENTAL HEALTH: USING POLICY CHANGE TO PROBE CAUSALITY1R01DA042195-01 · under PAR-13-080 | GRUCZA, RICHARD A | WASHINGTON UNIVERSITY, MO | $228,925 | ZRG1 |
| 2016 | Opioid Prescribing in Medicaid: Healthcare Utilization and Deaths from Overdose1R01DA039930-01A1 · under PAR-13-080 | JAYAWARDHANA, JAYANIPERRI, MATTHEW | UNIVERSITY OF GEORGIA, GA | $225,000 | ZRG1 |
| 2016 | E-Cigarette Use and Longitudinal Changes in Cigarette Smoking and Health1R01CA203809-01 · under PAR-13-080 | MCCABE, SEAN ESTEBAN | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $217,388 | ZRG1 |
| 2016 | The Long-term Costs and Benefits of Alcohol Treatments1R01AA024423-01A1 · under PAR-13-080 | BARBOSA, CAROLINA | RESEARCH TRIANGLE INSTITUTE, NC | $215,283 | ZRG1 |
| 2015 | Detection, Understanding and Reduction of Latino Health Care Disparities1R01DA038608-01A1 · under PAR-13-080 | GARNER, BRYAN RGUERRERO, ERICK | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $252,870 | ZRG1 |
| 2015 | Genes, Environment and Drug Use in Three Baltimore Cohorts1R01DA036525-01A1 · under PAR-13-080 | MAHER, BRION S | JOHNS HOPKINS UNIVERSITY, MD | $243,000 | ZRG1 |
| 2015 | Trajectories of Nonmedical Prescription Drug Misuse2R01DA031160-04 · under PAR-13-080 | MCCABE, SEAN ESTEBAN | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $232,500 | ZRG1 |
| 2015 | ADHD and Substance Problems in Adolescence: Specificity, Mechanisms, and Gender1R01DA038065-01A1 · under PAR-13-080 | ELKINS, IRENE J | UNIVERSITY OF MINNESOTA, MN | $228,000 | ZRG1 |
| 2015 | Age-Varying Effects in the Epidemiology of Drug Abuse1R01DA039854-01 · under PAR-13-080 | LANZA, STEPHANIE T | PENNSYLVANIA STATE UNIVERSITY, THE, PA | $226,050 | ZRG1 |
| 2015 | Borderline Personality and Inmates' Post-release Substance Abuse and HIV Risk Behavior1R01DA038128-01A1 · under PAR-13-080 | TANGNEY, JUNE P | GEORGE MASON UNIVERSITY, VA | $193,800 | ZRG1 |
| 2014 | Role of Childhood Cumulative Risk in Substance Misuse and Co-occurring Problems1R01DA038450-01 · under PAR-13-080 | MASON, W ALEXSAVOLAINEN, JUKKA K | FATHER FLANAGAN'S BOYS' HOME, NE | $255,393 | ZRG1 |
| 2014 | A Network Analytic Model of Adherence and Abstinence1R01DA035775-01A1 · under PAR-13-080 | BERNSTEIN, STEVEN L | YALE UNIVERSITY, CT | $247,461 | ZRG1 |
| 2014 | Generalizing RCT Efficacy Evidence: Application to NIDA Clinical Trials Network1R01DA036520-01 · under PAR-13-080 | MOJTABAI, RAMIN | JOHNS HOPKINS UNIVERSITY, MD | $243,000 | ZRG1 |
| 2014 | Imaging data re-analysis for cocaine addiction1R56DA036556-01A1 · under PAR-13-080 | WANG, ZE | UNIVERSITY OF PENNSYLVANIA, PA | $240,000 | ZRG1 |
| 2014 | Early Substance Use in Rural American Indian and White/Anglo Youth1R01DA036523-01A1 · under PAR-13-080 | SHANAHAN, LILLY | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $239,304 | ZRG1 |
| 2014 | Multi-modal MRI data fusion to assess neurobiological effects of marijuana use1R01DA037265-01 · under PAR-13-080 | NICKERSON, LISA D | MCLEAN HOSPITAL, MA | $237,000 | ZRG1 |
| 2014 | Peer Mechanisms in the Internalizing Pathway to Substance Use1R01DA037215-01 · under PAR-13-080 | HUSSONG, ANDREA M | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $232,576 | ZRG1 |
| 2014 | Maternal Age, Trajectories of Substance Use, and Health Disparities1R01DA037209-01 · under PAR-13-080 | DE GENNA, NATACHA | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $231,000 | ZRG1 |
| 2014 | Causal Inferences for treatment moderators on Zero-Inflated outcomes of HIV risk1R01DA036557-01A1 · under PAR-13-080 | GALLOP, ROBERT | UNIVERSITY OF PENNSYLVANIA, PA | $148,800 | ZRG1 |
| 2014 | Longitudinal Study of Trauma, HIV Risk, and Criminal Justice Involvement1R01DA036414-01A1 · under PAR-13-080 | KHAN, MARIA RABIA | UNIVERSITY OF FLORIDA, FL | $53,557 | BSPH |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.